Targeting the androgen receptor in prostate cancer--a resilient foe
- PMID: 25184629
- DOI: 10.1056/NEJMe1409306
Targeting the androgen receptor in prostate cancer--a resilient foe
Comment on
-
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.N Engl J Med. 2014 Sep 11;371(11):1028-38. doi: 10.1056/NEJMoa1315815. Epub 2014 Sep 3. N Engl J Med. 2014. PMID: 25184630 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical